ADJUSTED ADMINISTRATION OF A T-CELL UTILIZING BISPECIFIC ANTI CD3/GD2 CONSTRUCT AND CH14.18MAB IN RELATION TO IMMUNE RECOVERY AFTER ALLOGENEIC SCT IN PATIENTS WITH RELAPSED NEUROBLASTOMA

Resimmune (A-dmDT390-bisFv(UCHT1)) - Angimmune, AOP Orphan Pharma

https://www.professionalabstracts.com/ebmt2019/iplanner/#/list/%7B%22days%22:%5B%5D,%22types%22:%5B%5D,%22themes%22:%5B%5D,%22rooms%22:%5B%5D%7D

Anne-Marie Lang1; Gundram Jung2; Ursula Seidel1; Florian Heubach1; Armin Rabsteyn1; Patrick Schlegel1; Christian Seitz1; Rupert Handgretinger1; Peter Lang1

Mar 29, 2019